Cbiz report highlights rising costs: surge in inpatient and outpatient expenses, popular glp-1 drugs like ozempic drive pharmacy spend increase

Cleveland--(business wire)--cbiz, inc. (nyse: cbz), a leading national professional services advisor, announced the release of its 2025 state of healthcare report. the report provides a data-driven look at trends affecting employer-sponsored healthcare and the strategies organizations are using to stay competitive. now, more than ever, employers face increased pressure to balance affordability with employee wellbeing as healthcare costs continue to rise. the state of healthcare report draws on.
CBZ Ratings Summary
CBZ Quant Ranking